Exhibit 10.22
NEUMORA THERAPEUTICS, INC.
EXECUTIVE EMPLOYMENT AGREEMENT
This Executive Employment Agreement (the “Agreement) is entered into between Neumora Therapeutics, Inc., a Delaware corporation (the “Company”), and Jason Duncan (“Executive” and, together with the Company, the “Parties”) effective as of November 13, 2023 (the “Effective Date”).
WHEREAS, the Company desires to assure itself of the continued services of Executive by engaging Executive to perform services as an employee of the Company commencing December 11, 2023 (the date Executive actually commences employment with the Company, the “Commencement Date”) under the terms hereof; and
WHEREAS, Executive desires to provide continued services to the Company on the terms herein provided; and
NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, including the respective covenants and agreements set forth below, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:
[Signature Page Follows]
IN WITNESS WHEREOF, the Parties have duly executed this Agreement as of the date and year first above written.
NEUMORA THERAPEUTICS, INC.
By: /s/ Henry Gosebruch
Name: Henry Gosebruch
Title: Chief Executive Officer
EXECUTIVE
By: /s/ Jason Duncan
Name: Jason Duncan
Address: [****]
Exhibit A
PERMITTED OUTSIDE ACTIVITIES